BP
IRWD icon

Banyan Partners’s Ironwood Pharmaceuticals IRWD Stock Holding History

Banyan Partners’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$328K Hold
30,208
– – 0.03% 345
2014
Q2 		$388K Hold
30,208
– – 0.03% 332
2014
Q1 		$312K Hold
30,208
– – 0.03% 340
2013
Q4 		$294K Hold
30,208
– – 0.02% 361
2013
Q3 		$300K Hold
30,208
– – 0.03% 260
2013
Q2 		$251K Buy
+30,208
New +$366K 0.05% 162

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Banyan Partners's IRWD Position: Q3 2014 in Review

Banyan Partners held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2014 at 30,208 shares worth $328K. The position accounts for 0.03% of the portfolio, ranked #345.

Banyan Partners first reported a position in IRWD in Q2 2013 and has held it in 6 quarters since. The position peaked at $388K in Q2 2014. 140 funds tracked by Wall St. Rank hold IRWD as of Q3 2014.

  • Banyan Partners held 30,208 shares of Ironwood Pharmaceuticals worth $328K as of Q3 2014.
  • Banyan Partners left its Ironwood Pharmaceuticals share count unchanged in Q3 2014.
  • Ironwood Pharmaceuticals made up 0.03% of Banyan Partners's portfolio in Q3 2014, its #345 holding.
  • Banyan Partners first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • Banyan Partners's Ironwood Pharmaceuticals position peaked at $388K in Q2 2014.
  • 140 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.